Published in Antimicrob Agents Chemother on October 01, 1972
Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies. Antimicrob Agents Chemother (1974) 6.72
Cephamycins, a new family of beta-lactam antibiotics: antibacterial activity and resistance to beta-lactamase degradation. Antimicrob Agents Chemother (1973) 4.45
Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation. Antimicrob Agents Chemother (1974) 3.22
Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studies. Antimicrob Agents Chemother (1972) 2.25
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother (1974) 1.76
Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function. Antimicrob Agents Chemother (1980) 1.20
Cephamycin C treatment of induced enterotoxigenic colibacillosis (scours) in calves and piglets. Antimicrob Agents Chemother (1980) 0.81
Dithiolopyrrolone natural products: isolation, synthesis and biosynthesis. Mar Drugs (2013) 0.80
Cephamycin C treatment of induced swine salmonellosis. Antimicrob Agents Chemother (1981) 0.77
Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n. Antimicrob Agents Chemother (1972) 5.23
Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studies. Antimicrob Agents Chemother (1972) 2.25
Cephaloridine activity in vitro and absorption and urinary excretion in normal young men. Am J Med Sci (1966) 2.09
Cephalosporins. Med Clin North Am (1970) 1.53
The place of the cephalosporins in medicine. Postgrad Med J (1970) 1.20
A protein interaction map of Drosophila melanogaster. Science (2003) 20.06
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrob Agents Chemother (1980) 9.02
Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. Antimicrob Agents Chemother (1974) 8.84
The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci (1974) 7.21
Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies. Antimicrob Agents Chemother (1974) 6.72
Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother (1979) 5.88
Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase. Antimicrob Agents Chemother (1982) 5.83
Thienamycin: development of imipenen-cilastatin. J Antimicrob Chemother (1983) 5.52
Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n. Antimicrob Agents Chemother (1972) 5.23
Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother (1997) 4.87
Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J Antibiot (Tokyo) (1979) 4.82
Cephamycins, a new family of beta-lactam antibiotics: antibacterial activity and resistance to beta-lactamase degradation. Antimicrob Agents Chemother (1973) 4.45
Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors. Antimicrob Agents Chemother (1983) 4.25
Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science (1969) 3.89
Antibacterial agents that inhibit lipid A biosynthesis. Science (1996) 3.38
Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation. Antimicrob Agents Chemother (1974) 3.22
Cefoxitin, a semi-synthetic cephamycin: a microbiological overview. J Antimicrob Chemother (1978) 2.75
Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrob Agents Chemother (1997) 2.73
Two vivax malaria cases detected in Korea. Korean J Parasitol (1994) 2.69
Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother (1995) 2.62
Detection of antibodies in serum and cerebrospinal fluid to Toxoplasma gondii by indirect latex agglutination test and enzyme-linked immunosorbent assay. Kisaengchunghak Chapchi (1992) 2.58
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob Agents Chemother (1995) 2.37
Ivermectin: a potent new antiparasitic agent. Science (1983) 2.31
beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis (1992) 2.27
Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studies. Antimicrob Agents Chemother (1972) 2.25
In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrob Agents Chemother (1998) 2.13
Antibacterial activity of imipenem: the first thienamycin antibiotic. Rev Infect Dis (1985) 2.00
A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis. J Infect Dis (1999) 1.91
Crystal structures of the Klenow fragment of Thermus aquaticus DNA polymerase I complexed with deoxyribonucleoside triphosphates. Protein Sci (1998) 1.90
Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. Am J Med (1985) 1.90
Pulmonary paragonimiasis: clinical and experimental studies. Radiographics (1993) 1.86
Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates. Antimicrob Agents Chemother (1997) 1.80
The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation (1978) 1.75
Alternative forms of rat TrkC with different functional capabilities. Neuron (1993) 1.70
Cerebral paragonimiasis in early active stage: CT and MR features. AJR Am J Roentgenol (1994) 1.68
Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser. Neuropathol Appl Neurobiol (1980) 1.67
The nature of treatment selection in coronary artery disease. Experience with medical and surgical treatment of a chronic disease. Circulation (1974) 1.59
Reduction of paraphimosis with hyaluronidase. Urology (1996) 1.59
Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles. Tissue Antigens (1995) 1.59
In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates. Antimicrob Agents Chemother (1999) 1.57
Graded exercise stress tests in angiographically documented coronary artery disease. Circulation (1974) 1.51
Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial. Lupus (2012) 1.50
Pharmacokinetic studies of norfloxacin in laboratory animals. Chemotherapy (1984) 1.44
Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis (1989) 1.43
Pedicle morphology in thoracic adolescent idiopathic scoliosis: is pedicle fixation an anatomically viable technique? Spine (Phila Pa 1976) (2000) 1.39
Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res (1999) 1.39
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science (1985) 1.39
Phosphonomycin. V. Evaluation in mice. Antimicrob Agents Chemother (Bethesda) (1969) 1.38
L-lysine epsilon-aminotransferase involved in cephamycin C synthesis in Streptomyces lactamdurans. Antimicrob Agents Chemother (1980) 1.36
Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J Immunol (1979) 1.34
Outcome in one-vessel coronary artery disease. Circulation (1983) 1.34
Risk factors in coronary artery bypass surgery. Arch Surg (1972) 1.33
Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene (2006) 1.31
Metacercarial infections of Paragonimus westermani in freshwater crabs sold in markets in Seoul. Kisaengchunghak Chapchi (1991) 1.29
Clonorchis sinensis: molecular cloning and characterization of 28-kDa glutathione S-transferase. Exp Parasitol (2001) 1.27
Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol (1999) 1.26
Exercise stress testing in evaluation of aortocoronary bypass surgery. Report of 123 patients. Circulation (1973) 1.24
Cysteine protease activities during maturation stages of Paragonimus westermani. J Parasitol (1997) 1.24
Comparison of angiographic and postmortem findings in patients with coronary artery disease. Am J Cardiol (1975) 1.23
Automated differential cell counting on a sector of the normal human hippocampus: the influence of age. Neuropathol Appl Neurobiol (1984) 1.23
Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans. Drug Metab Dispos (2000) 1.23
The natural history of right coronary arterial occlusion in the pig. Comparison with left anterior descending arterial occlusion. Am J Cardiol (1970) 1.21
Phosphonomycin. IV. Susceptibility testing method and survey. Antimicrob Agents Chemother (Bethesda) (1969) 1.21
Excystment of Paragonimus westermani metacercariae by endogenous cysteine protease. J Parasitol (1995) 1.21
Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc Natl Acad Sci U S A (2001) 1.20
A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis (2004) 1.20
Immunoblot analysis of a 10 kDa antigen in cyst fluid of Taenia solium metacestodes. Parasite Immunol (1998) 1.19
The winged-helix/forkhead protein myocyte nuclear factor beta (MNF-beta) forms a co-repressor complex with mammalian sin3B. Biochem J (2000) 1.18
Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. Am J Trop Med Hyg (1998) 1.18
Fosfomycin: Laboratory studies. Chemotherapy (1977) 1.17
Discovery of inhibitory activity of tenuazonic acid for growth of human adenocarcinoma-1. Biochem Biophys Res Commun (1964) 1.15
Activities of different cysteine proteases of Paragonimus westermani in cleaving human IgG. Korean J Parasitol (1997) 1.15
Epidemiology of paragonimiasis in Korea. Southeast Asian J Trop Med Public Health (1997) 1.14
Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J (2001) 1.14